|[January 31, 2013]
Analyte Health Names Chief Medical Officer and Chief Compliance Officer
CHICAGO --(Business Wire)--
Health, Inc., a privately held online healthcare company offering
specialty care, counseling and convenience not available in traditional
primary care settings, today announced a strategic expansion of its
executive team with the addition of Dr.
Ramesh Subramani as Chief Medical Officer and Karen
Soares as Chief Compliance Officer. Both join the company as more
and more Americans turn to online healthcare resources such as Analyte
Health to access services.
Analyte Health currently provides its services via the web, phone and
mobile devices to individuals at risk for sexually transmitted diseases
(STDs) through online clinics including SexualHealth.com
About Ramesh Subramani MD, MBA, MPH, Chief Medical Officer
ER physician, social entrepreneur, venture capitalist and former
McKinsey consultant, Subramani brings unique expertise to Analyte
Health's executive team. Having previously been an investor in
diagnostic companies at New Leaf Ventures, he believes that advances in
diagnostics can dramatically reduce healthcare costs and keep people
healthier bypreventing and preempting disease. He brings experience
working with insurers, pharma, medical devices, public health and
non-profits to help engage Analyte within the healthcare ecosystem. As
an ER physician who previously worked at Northwestern University,
University of Chicago, and Columbia University, he will also drive the
medical vision and standards for Analyte. Subramani will report directly
to Analyte Health CEO Sridhar
About Karen Soares, Chief Compliance Officer
Steeped in healthcare law during her tenure as a litigation associate at
Fried, Frank, Harris, Shriver & Jacobson LLP in Washington, DC, Soares
brings to Analyte Health a keen understanding of the dynamic environment
of healthcare compliance. She is charged with leading the internal
compliance team and providing oversight on all related policies and
procedures at Analyte Health. Soares also will oversee the company's
ongoing compliance initiatives, including leading workforce education
efforts, managing internal audits and regulatory reporting. She will
report directly to Murthy as well.
"Healthcare services are rapidly evolving in America," said Analyte CEO
Murthy. "During this time of intense change, it is important that
Analyte Health holds itself to the highest standards of quality care and
professional services. We continue to build an executive team that is
unmatched among online healthcare services providers. The addition of
Ramesh and Karen will fortify the already strong cadre of licensed
doctors associated with the company and ensure compliance with
healthcare laws and regulations."
Among the market trends driving the growth of Analyte Health and health
2.0 in general are the declining population of physicians, the projected
rise in demand for services as a result of the Affordable Care Act
(ACA), scientific advances in molecular diagnostics and technology that
addresses people's overbooked schedules and enables them to access
health services at their convenience.
"Analyte Health is uniquely positioned in this changing environment,"
adds Murthy, "to reduce barriers to diagnosis and care and to have a
positive impact on public health. Ramesh and Karen will help Analyte
continue to deliver healthcare consumers a true alternative to meeting
their healthcare needs."
About Analyte Health, Inc.
Analyte Health is an innovative healthcare company based in Chicago that
uses technology to help people gain expert medical care and information.
Analyte Health delivers specialty care, counseling and convenience not
available in a traditional primary care setting. Analyte Health offers
individuals access via the web, mobile devices and telephone to a
dedicated national team of doctors, nurses and health experts as well as
more than 4,000 partner testing centers. Through more than 86,000
patient encounters to date, patients have trusted Analyte Health to
deliver discreet and convenient STD testing and care. More information
about the company is available at www.AnalyteHealth.com or
on Facebook (News - Alert) at https://www.facebook.com/SexHealthDotCom,
Twitter (News - Alert) at https://twitter.com/sexualhealth.
Analyte Health, Inc. is a privately held company. This press release may
be deemed to contain forward-looking statements, which are subject to
the safe harbor provisions of the Private Securities Litigation Reform
Act of 1995, including statements regarding the expected benefits to
consumers from using Analyte Health's services. Readers are cautioned
that these forward-looking statements are only predictions and may
differ materially from actual future events or results due to a variety
of risks and uncertainties, including, among other things, the potential
impact of regulatory and third party payer developments in the field of
telehealth and STD testing, general business and economic conditions,
changes in arrangements with vendors or suppliers, and costs or delays
in obtaining or maintaining regulatory approvals and licenses. Any
forward-looking statements in this release are based on limited
information currently available to Analyte Health, which is subject to
change, and Analyte Health will not necessarily update the information.
[ Back To TMCnet.com's Homepage ]